Arena rallies on new Belviq agreement


Arena Pharmaceuticals (ARNA) rises 6.6% premarket.

Investors appear pleased with the expanded agreement between ARNA and Eisai for Belviq.

From other sites
Comments (5)
  • Iqbal1
    , contributor
    Comments (54) | Send Message
     
    If we really pay attention to negative propaganda will realized that it is from short seller or their agents the stock in my opinion deserve fair move up it is not because I am long but it is below prior to approval level.
    8 Nov 2013, 09:11 AM Reply Like
  • engbulldog3
    , contributor
    Comments (205) | Send Message
     
    OOPs they forgot to mention ARNA beat est.. on earnings per share. And a YTS sales of approx. $75 mil ytd. Estimate for the year approx., $80 mil. Thanks
    8 Nov 2013, 11:02 AM Reply Like
  • WIS JOE
    , contributor
    Comments (57) | Send Message
     
    The market is aware of Belviq's value and as others see this equity move positive as is the case, the shorts will diminish as they have already from 40% to the 20% range and even to little or no short position at all. These shorts are forced to purchase ARNA in an effort to stop losses, forcing the price higher. It is time to watch the resistance levels as Arena moves higher. These resistant levels now have become buying opportunities Its time for us longs to reap the rewards of our beliefs.

     

    8 Nov 2013, 02:22 PM Reply Like
  • PEhrlich
    , contributor
    Comments (1702) | Send Message
     
    Congrats you guys. $60M upfront is a pretty big vote of confidence from Eisai.
    8 Nov 2013, 04:30 PM Reply Like
  • Iqbal1
    , contributor
    Comments (54) | Send Message
     
    Hi Joe & others excellent posts
    Havee a Nice day
    9 Nov 2013, 08:21 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs